Zenith Bank Plc (LON:ZENB)

Verve Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,548	740	1,072	1,396	1,413	1,495
Market Cap Growth	14.88%	-30.92%	-23.23%	-1.22%	-5.48%	22.73%
Last Close Price	2.19	2.23	2.09	2.13	1.83	1.61
PE Ratio	2.82	1.38	1.79	3.36	3.23	3.38
PS Ratio	1.32	0.65	0.96	1.21	1.39	1.52
PB Ratio	0.69	0.36	0.52	0.55	0.62	0.70
Debt / Equity Ratio	0.82	0.58	0.76	0.94	0.94	1.19
Return on Equity (ROE)	29.80%	32.52%	36.57%	16.84%	20.40%	22.39%
Return on Assets (ROA)	3.83%	4.11%	4.15%	2.06%	2.73%	3.11%
Earnings Yield	35.44%	72.29%	55.75%	29.73%	30.95%	29.59%
FCF Yield	-167.38%	-433.66%	-312.76%	-165.94%	-93.57%	-100.67%
Dividend Yield	3.62%	0.12%	0.17%	0.28%	0.30%	0.36%
Payout Ratio	26.01%	13.68%	15.78%	43.46%	38.55%	38.16%
Buyback Yield / Dilution	-7.79%	-0.09%	-	-	-	-
Total Shareholder Return	-4.17%	0.03%	0.17%	0.28%	0.30%	0.36%

Source: S&P Global Market Intelligence. Banks template. Financial Sources.